Navigation Links
Partnership of genes affects the brain's development
Date:2/13/2011

The human brain consists of approximately one hundred billion nerve cells. Each of these cells needs to connect to specific other cells during the brain's development in order to form a fully functional organism. Yet how does a nerve cell know where it should grow and which cells to contact? Scientists of the Max Planck Institute of Neurobiology in Martinsried have now shown that growing nerve cells realise when they've reached their target area in the fly brain thanks to the interaction of two genes. Similar mechanisms are also likely to play a role during the development of the vertebrate brain and could thus be important for a better understanding of certain developmental disorders.

The nervous system is incredibly complex. Millions and even many billion nerve cells are created during development. Each of these cells sets up connections to their neighbouring cells and then sends out a long connecting cable, the axon, to a different brain region. Once the axon has reached its target area it connects itself with the local nerve cells. In this way a processing chain is established which allows us, for example, to see a cup, recognize it as such, reach out and take hold of it. Had there been a misconnection between the nerve cells somewhere along the way between the eyes and the hand, it would be impossible to reach the coffee in the cup.

It is thus essential for nerve cells to connect to the correct partner cells. Based on this fact, scientists of the Max Planck Institute of Neurobiology in Martinsried and colleagues from Kyoto investigated how an axon knows where it should stop growing and start setting up connections with surrounding cells. For their investigation, the neurobiologists analyzed the function of genes that play a role in the development of the visual system of the fruit fly.

The scientists now report in the scientific journal Nature Neuroscience that the visual system of the fruit fly is only able to develop correctly, when two genes work together the genes, that are in charge of producing the proteins "Golden Goal" and "Flamingo". These two proteins are located at the tip of a growing axon, where they are believed to gather information about their environment from the surrounding tissue. The actions of these two proteins enable nerve cells in a number of ways to find their way in the brain and recognize their target area. The study showed that chaos results if only one of the genes is active, or if there is a mismatch in the genes' activity: the axons cease to grow somewhere along the way and never reach their target area.

"We assume that very similar mechanisms play a role also in other organisms including humans", explains Takashi Suzuki, lead author of the study. "We are now a good way into understanding how to manipulate the cells in such a way that they are certain to reach their target area." This knowledge would be an important foundation for eventual therapies of developmental disorders based upon a misguided growth of nerve cells. The knowledge may also help in the guidance of regenerating nerve cells back to their old connection sites.


'/>"/>

Contact: Stefanie Merker
merker@neuro.mpg.de
49-898-578-3514
Max-Planck-Gesellschaft
Source:Eurekalert  

Related biology news :

1. Tufts announces public launch of the Tufts Institute for Biomedical Partnerships website/HUB
2. memsys-NTU partnership to enhance water desalination technology
3. Partnership Is Game-Changer for the Future of eCommerce
4. Agilent Technologies Expands Agreement to Offer AMDeC Members Preferential Pricing on Products Through AMDeC F.I.R.S.T.â„¢ Vendor Partnership Program
5. UMD to lead $5 million NSF-funded research partnership to develop drought-tolerant canola crops
6. From bees to coral reefs: How humans impact partnerships in the natural world
7. NJIT to help lead public/private partnership to develop high-efficiency homes
8. University of Maryland partnership receives $7.9M from NIH for superconducting research magnet
9. Symposium to explore broadening partnerships to spur medical advances for war injuries
10. A baby, Skype and water research partnership with Israel
11. Wellcome-Wolfson partnership makes £30 million investment in UK scientific infrastructure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Partnership of genes affects the brain's development
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: